EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb 6, 2013--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Monday, February 11, at 4:00 p.m. CT.
Gary Maharaj, president and chief executive officer, Tim Arens, vice president of finance and interim chief financial officer, and Bob Buhrmaster, chairman of the board, will provide an overview of the broad outlook for the Company, and discuss financial results and achievements for the fiscal year ended September 30, 2012 as well as results from the first quarter of fiscal year 2013.
To access the webcast, go to the investor relations portion of the Company's website at www.surmodics.com on the day of the Annual Meeting and click on the webcast icon. In addition, the Annual Meeting audio and slide presentation will be archived on the Company's website following the meeting.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit http://www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.